Brilinta 90mg Tablet belongs to the antiplatelet agent category, containing the active ingredient Ticagrelor. It is used to prevent blood clots in patients with acute coronary syndrome (ACS), including unstable angina or myocardial infarction (heart attack).
This drug is contraindicated in individuals with known hypersensitivity or allergic reactions to other ingredients in it. If you are scheduled for surgery (including dental work), it is important to inform your doctor. Due to the increased risk of bleeding associated with this drug, your physician may advise you to stop taking the medication five days prior to the surgery. If you develop irregular breathing patterns such as speeding up, slowing down, or experiencing short pauses in breathing, it is recommended to consult your doctor for further evaluation.
Brilinta 90mg Tablet is not recommended during pregnancy or if there is a possibility of becoming pregnant. It is advised for women to use appropriate contraceptive measures to prevent pregnancy while using this medication. If you are breastfeeding, it's important to consult with your physician before taking this drug. This drug is not recommended for children and adults under 18 years of age.
Uses of Brilinta 90mg Tablet 14'sPrevent blood clots in patients with acute coronary syndrome (ACS) Therapeutic Effects of Brilinta 90mg Tablet 14's
Brilinta 90mg Tablet works by inhibiting platelet activation and aggregation. It specifically blocks a receptor called P2Y12 on the platelets, preventing them from clumping together and forming blood clots. This helps reduce the risk of heart-related events in individuals with ACS. Interaction of Brilinta 90mg Tablet 14's with other drugsInform your physician about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications such as rosuvastatin, rifampicin, phenytoin, digoxin, cyclosporine, verapamil and opioids may interact with Brilinta 90mg Tablet and reduce effectiveness by causing undesirable side effects.More Information about Brilinta 90mg Tablet 14's Do not store Brilinta 90mg Tablet above (30°C).Keep out of reach of children.How to consume Brilinta 90mg Tablet 14'sTake the Brilinta 90mg Tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.Safety Advices for Brilinta 90mg Tablet 14's
Pregnancy
Brilinta 90mg Tablet is not recommended during pregnancy or if there is a possibility of becoming pregnant. It is advised for women to use appropriate contraceptive measures to prevent pregnancy while using this medication.
Breast Feeding
If you are breastfeeding, it's important to consult with your physician before taking Brilinta 90mg Tablet.
Lungs
Inform your doctor if you have lung disease because the Brilinta 90mg Tablet should be used cautiously with a lung condition.
Liver
It is unknown whether Brilinta 90mg Tablet is safe for patients with liver problems. Inform your physician if you have liver disease before starting the treatment.
Alcohol
It is unknown whether consuming alcohol interacts with Brilinta 90mg Tablet. Please consult your doctor for more advice.
Driving
Brilinta 90mg Tablet are not known to cause drowsiness or impair driving ability, so they are generally considered safe for use while driving or operating machinery.
Side Effects of Brilinta 90mg Tablet 14'sSide effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.Serious
- Shortness of breath
- Blood clotting problem called TTP (purplish spots in the mouth or mouth, fever, confusion, yellowing of the eyes or skin, fever)
- Fainting
- Bleeding (red or black stools, coughing up or vomiting with blood, red, pink, or brown urine)
Common
- Headache
- Indigestion
- Nausea
- Constipation
- Rash, itching
- Pain and swelling in the joints
- Blurred vision
- Bleeding gums
- Bruising
Word of AdviceSince Brilinta 90mg Tablet affects platelet production, it's essential to take precautions to avoid injuries and bleeding. Be cautious when engaging in activities that may increase your risk of injury, and report any unusual bleeding or bruising to your physician.FAQs Q 1. How does Brilinta 90mg Tablet work?Brilinta 90mg Tablet works by inhibiting platelet activation and aggregation. It specifically blocks a receptor called P2Y12 on platelets, which prevents them from sticking together and forming blood clots. This helps maintain blood flow and reduce the risk of cardiovascular events in patients with ACS.
Q 2. How is Brilinta 90mg Tablet taken?Brilinta 90mg Tablet is taken orally in tablet form. The usual recommended dose for ACS patients is 180 mg as a loading dose, followed by 90 mg twice daily. It is important to follow the dosing instructions provided by your physician.
Q 3. What are the common side effects of Brilinta 90mg Tablet?Common side effects of Brilinta 90mg Tablet may include bleeding, shortness of breath, headache, dizziness, nausea, and fatigue. It is important to seek medical attention if you experience any signs of bleeding, such as prolonged or excessive bleeding from cuts, blood in urine or stool, or unexplained bruising.
Q 4. Are there any drug interactions with Brilinta 90mg Tablet?Brilinta 90mg Tablet may interact with other medications, including prescription drugs, over-the-counter medications, and herbal supplements. It is necessary to inform your physician about all the medications you are taking to avoid potential interactions that may affect the safety or efficacy of this drug.
Q 5. Is it ok if I miss a dose of Brilinta 90mg Tablet?If you miss a dose of Brilinta 90mg Tablet, take it as soon as you remember and then continue with your regular dosing schedule. Do not take a double dose to make up for a missed dose unless advised by your physician.
Fact Box of Brilinta 90mg Tablet 14'sMolecule name: Ticagrelor | Therapeutic class: Antiplatelet agents |
Pharmacological class: Platelet aggregation inhibitors | Indications: Prevent blood clots in patients with acute coronary syndrome (ACS) |
